QureTech Bio expands workforce following major investment
QureTech Bio expands workforce following major investmentApril, 2021Umeå-based pharmaceutical development [...]
QureTech Bio Looks to the Future With Appointment of New CEO
QureTech Bio Looks to the Future With Appointment of New [...]
Professor Scott Hultgren, CSO of QureTech Bio, elected fellow of the National Academy of Inventors
Scott Hultgren, CSO of QureTech Bio and Helen L. Stoever [...]
Umeå researcher wants to save millions of lives with new antibiotics
Fredrik Almqvist, CEO of QureTech Bio based in Umeå in [...]
QureTech Bio secures SEK 14 million investment – a very important milestone in their fight against antibiotic resistance
Venture capital company Nascent Invest has bought shares in Umeå-based [...]
QureTech Bio has secured a US patent for tuberculosis treatment
Umeå-based QureTech Bio has received preliminary approval for a patent [...]
QureTech Bio granted millions to fight antibiotic resistance
Umeå life science company QureTech Bio has received a SEK [...]
Awarded millions in fight against antibiotic resistance
Researchers from the Umea pharmaceutical research company Quretech Bio have [...]
Researchers from Quretech Bio AB awarded additional funding
Researchers from Quretech Bio AB (Quretech Bio) in Umeå, who [...]
Quretech Bio – fighting bacterial virulence
Quretech Bio develops innovative antibiotics by stopping bacterial virulence with [...]